Pricing Log in Create free account

BioCardia, Inc. (BCDA) vs CASI Pharmaceuticals Inc. (CASIF)

BioCardia, Inc. and CASI Pharmaceuticals Inc. are both Biotechnology companies. BioCardia, Inc. and CASI Pharmaceuticals Inc. are of similar size ($13.5M and $12.4M). BioCardia, Inc. grew revenue faster over the last twelve months: 0.71% against −27.4%. BioCardia, Inc. has the higher net margin (0.00% vs −232.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, BioCardia, Inc. leads on 10 and CASI Pharmaceuticals Inc. on 6.

Valuation

Metric BCDA CASIF Biotechnology median
P/E n/m n/m 10.60
P/S 24.58 0.10 9.40
P/B 3.90 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 28.74 1.80 9.02
Earnings yield (87.99%) (2,455.91%) (32.88%)
Free cash flow yield (71.97%) (3,455.46%) (23.13%)

Profitability

Metric BCDA CASIF Biotechnology median
Gross margin 100.00% 48.65% 68.51%
Operating margin 0.00% (206.87%) 0.00%
Net margin 0.00% (232.03%) 0.00%
Free cash flow margin 0.00% (340.20%) 0.00%
Return on equity (1,803.19%) 0.00% (51.96%)
Return on assets (214.47%) 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BCDA CASIF Biotechnology median
Revenue growth (TTM) 0.71% (27.42%) 6.76%
EPS growth (last fiscal year) 57.59% (1.17%) 29.88%
Revenue growth, 5-year CAGR 26.89% 6.47% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BCDA CASIF Biotechnology median
Debt to equity 0.00 (0.34) 0.00
Current ratio 2.09 0.15 4.97
Net debt to EBITDA 0.30 (0.43) 1.01

Dividend

Metric BCDA CASIF Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BCDA CASIF Biotechnology median
Market cap 13.47m 12.39m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack